TRIIM thymus regeneration (GH + DHEA + metformin)
Availability Clinical trials only
What it is
A one-year trial protocol combining recombinant human growth hormone with DHEA and metformin. The target is the thymus, the gland that trains T cells and fills with fat as people age. The DHEA and metformin are in the mix to offset growth hormone's effect on blood sugar.
Why people follow this protocol
It produced the first published report of human epigenetic age running backwards, which is the most quoted result in the field. The appeal is twofold: a regrown thymus as a route to a younger immune system, and a clock reading to show for it.
How it's delivered
Inside a trial, and only there. Participants self-administer daily growth hormone injections alongside oral DHEA and metformin for a year, with thymus imaging and immune panels throughout. In the United States, distributing growth hormone for anti-aging is a federal offense, which closes off any off-trial route.
Where the evidence stands
The 2019 report followed nine men aged 51 to 65 for twelve months. Thymic fat gave way to tissue in seven, several immune markers improved, and mean epigenetic age finished about 1.5 years below baseline, roughly 2.5 years below the expected trajectory. There was no control group and no randomization, so a year of intensive medical attention cannot be separated from the drugs. Nine people is a pilot, not a finding. The larger follow-up, TRIIM-X, is enrolling and has published nothing. Growth hormone brings insulin resistance, fluid retention, and joint pain with it.
Estimated cost
There is no market price because there is no lawful market: the protocol exists only inside trial participation, with TRIIM-X enrolling adults aged 40 to 80, and distributing growth hormone for anti-aging is a federal offense in the United States. The one real anchor is the component cost, since somatropin runs four figures monthly where lawfully prescribed for approved indications, and insurance covers none of this for aging use.
Who offers it
- TrialIntervene Immune (TRIIM-X, NCT04375657)
Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.
Go deeper
No thymus regeneration guide yet. The science of aging hub covers epigenetic clocks and what a shifted reading does and does not establish.
Longevity.io is for educational purposes only and is not medical advice. This protocol exists as research, and questions about eligibility belong to the trial investigators and a clinician who knows the whole picture.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
